Corrigendum: The Research Progress of Direct KRAS G12C Mutation Inhibitors

Pathol Oncol Res. 2022 Feb 24:27:1610250. doi: 10.3389/pore.2021.1610250. eCollection 2021.

Abstract

[This corrects the article DOI: 10.3389/pore.2021.631095.].

Keywords: KRAS mutation; inhibitor; oncogene; oncology; targeted drugs.

Publication types

  • Published Erratum